by Don McLean | Feb 28, 2019 | Blog
How #OneMMS Actively Supports Rare Disease Day by Staff writer Rare diseases are often overlooked, but they affect many individuals. There may be as many as 7,000 rare diseases affecting approximately 25-30 million people in the US alone, according to the National...
by Don McLean | Jan 31, 2019 | Uncategorized
Tips for Nonclinical Pharmacology and the Medical Writers that Draft Regulatory Submissions by September Mihaly, Ph.D., RAC Summarizing nonclinical studies in Module 2.6 of the common technical document (CTD) takes a unique skillset. These studies include...
by Don McLean | Aug 16, 2018 | Blog
Four ways to produce stronger documents the first time by Staff writer “The quickest way to negatively impact timelines is to have quality issues that require rework,” said Regina Parott, Senior Manager, Medical Writing & Transparency, MMS. This was a key point...
by curtis@digitalliance.com | Jun 21, 2018 | Blog
11 traits to transition from a bench scientist to a medical writer by Ingrid Hansen, MS Many Ph.D. graduate students are led to believe that there are only two routes to take after graduation: Research projects in academia or industry. On the contrary, one thing that...
by curtis@digitalliance.com | May 31, 2018 | Blog
Ask the expert: The future of drug development by Staff writer The size of the global pharmaceutical market will reach $1.12 trillion by the year 2022, according to Pharmaceutical Commerce. Yet, many questions linger about what the future of drug development will look...
